The Nilsson Group is currently involved in a number of research projects that focus on understanding haemopoietic stem cells (HSC). Haemopoietic stem cells are responsible for the production of blood and immune cells.
They are a very important part of the body as they are constantly renewing blood. They create billions of new blood cells each day. They are located in the bone marrow, which is the flexible tissue inside most bones.
The main objective of the group’s research is to characterise the microenvironment in which blood stem cells reside. They also look at blood stems cells at a cellular and molecular level, as well as analysing how they create new blood cells.
Learning more about normal and diseased stem cells will lead to better prevention, clinical diagnosis and treatment. This will ultimately improve human health. An example of this is better bone marrow transplantation outcomes in cancer patients because they will be able to replace normal cells that are destroyed during anticancer therapy. Essentially, it will allow higher doses of chemotherapy or radiation to be given which will be a more effective form of treatment.